123 related articles for article (PubMed ID: 1936289)
1. Randomized clinical trials in surgical oncology.
Buyse M
Eur J Surg Oncol; 1991 Oct; 17(5):421-8. PubMed ID: 1936289
[TBL] [Abstract][Full Text] [Related]
2. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
3. Improving the design of phase II trials of cytostatic anticancer agents.
Stone A; Wheeler C; Barge A
Contemp Clin Trials; 2007 Feb; 28(2):138-45. PubMed ID: 16843736
[TBL] [Abstract][Full Text] [Related]
4. Non-inferiority trials in surgical oncology.
Fueglistaler P; Adamina M; Guller U
Ann Surg Oncol; 2007 May; 14(5):1532-9. PubMed ID: 17294075
[TBL] [Abstract][Full Text] [Related]
5. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
6. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
[TBL] [Abstract][Full Text] [Related]
7. Implementing a decision-theoretic design in clinical trials: why and how?
Palmer CR; Shahumyan H
Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
[TBL] [Abstract][Full Text] [Related]
8. The role of prospective randomized clinical trials in pediatric surgery: state of the art?
Moss RL; Henry MC; Dimmitt RA; Rangel S; Geraghty N; Skarsgard ED
J Pediatr Surg; 2001 Aug; 36(8):1182-6. PubMed ID: 11479852
[TBL] [Abstract][Full Text] [Related]
9. Surgeons: A Future Role in Clinical Trials?
Rusch VW
Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
[TBL] [Abstract][Full Text] [Related]
10. Design and endpoints of clinical trials in hepatocellular carcinoma.
Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
[TBL] [Abstract][Full Text] [Related]
11. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
12. Trustworthy alteration and improvement in adjuvant treatment of colon cancer.
Harlak A; Soran A
Med Sci Monit; 2006 Mar; 12(3):RA46-52. PubMed ID: 16501433
[TBL] [Abstract][Full Text] [Related]
13. [Recent progress of clinical trials in urologic oncology].
Hinotsu S
Gan To Kagaku Ryoho; 2006 Feb; 33(2):188-92. PubMed ID: 16484854
[TBL] [Abstract][Full Text] [Related]
14. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
Carroll KJ
Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
[TBL] [Abstract][Full Text] [Related]
15. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
16. Current trials and new aspects in soft tissue sarcoma of adults.
Issels RD; Schlemmer M
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
18. Improving the quality of reporting randomized controlled trials in cardiothoracic surgery: the way forward.
Tiruvoipati R; Balasubramanian SP; Atturu G; Peek GJ; Elbourne D
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):233-40. PubMed ID: 16872940
[TBL] [Abstract][Full Text] [Related]
19. [Reappraisal of Zelen's method in randomized controlled trials].
Hamajima N
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1953-7. PubMed ID: 1417003
[TBL] [Abstract][Full Text] [Related]
20. A clinical development paradigm for cancer vaccines and related biologics.
Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
